These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 10100579)

  • 21. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G
    Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
    Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
    Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M; Letizia C; Ragno A; Minisola S; D'Erasmo E; Mazzuoli GF
    Minerva Med; 2002 Dec; 93(6):471-8. PubMed ID: 12515970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
    Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
    Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
    Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
    J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients.
    Baek KH; Jeon HM; Lee SS; Lim DJ; Oh KW; Lee WY; Rhee EJ; Han JH; Cha BY; Lee KW; Son HY; Kang SK; Kang MI
    Bone; 2008 Jan; 42(1):61-7. PubMed ID: 17942383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
    Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
    Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of early risedronate treatment on bone mineral density and bone turnover markers after liver transplantation: a prospective single-center study.
    Guadalix S; Martínez-Díaz-Guerra G; Lora D; Vargas C; Gómez-Juaristi M; Cobaleda B; González EM; Hawkins F
    Transpl Int; 2011 Jul; 24(7):657-65. PubMed ID: 21466595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months.
    Wang WQ; Ip MS; Tsang KW; Lam KS
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium.
    Cross NA; Hillman LS; Allen SH; Krause GF
    J Bone Miner Res; 1995 Sep; 10(9):1312-20. PubMed ID: 7502702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone loss after heart transplantation: a prospective study.
    Sambrook PN; Kelly PJ; Keogh AM; Macdonald P; Spratt P; Freund J; Eisman JA
    J Heart Lung Transplant; 1994; 13(1 Pt 1):116-20; discussion 121. PubMed ID: 8167116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.
    Schulte C; Beelen DW; Schaefer UW; Mann K
    Osteoporos Int; 2000; 11(4):344-53. PubMed ID: 10928225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells.
    Lee WY; Cho SW; Oh ES; Oh KW; Lee JM; Yoon KH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2002 Jan; 87(1):329-35. PubMed ID: 11788670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone density loss during treatment of chronic GVHD.
    Stern JM; Chesnut CH; Bruemmer B; Sullivan KM; Lenssen PS; Aker SN; Sanders J
    Bone Marrow Transplant; 1996 Mar; 17(3):395-400. PubMed ID: 8704693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone loss in patients with untreated chronic obstructive pulmonary disease is mediated by an increase in bone resorption associated with hypercapnia.
    Dimai HP; Domej W; Leb G; Lau KH
    J Bone Miner Res; 2001 Nov; 16(11):2132-41. PubMed ID: 11697811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients.
    McClune BL; Polgreen LE; Burmeister LA; Blaes AH; Mulrooney DA; Burns LJ; Majhail NS
    Bone Marrow Transplant; 2011 Jan; 46(1):1-9. PubMed ID: 20729922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
    Baek KH; Lee WY; Oh KW; Kim HS; Han JH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1246-54. PubMed ID: 15001618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
    Kananen K; Volin L; Laitinen K; Alfthan H; Ruutu T; Välimäki MJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3877-85. PubMed ID: 15797959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.